Exploring ID4 as a Driver of Aggression and a Therapeutic Target in Triple-Negative Breast Cancer
C. Toro, Sebastián Real, Sergio R. Laurito, Marı́a Teresita Branham
This study identifies ID4 as a driver of aggressive basal-like breast cancer and shows that its inhibition reduces tumor growth and metastasis, suggesting it as a therapeutic target.
npj Breast Cancer · Jul 10, 2025Peer-reviewedCancer Biology